TrialMediators of inflammation2017

A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease.

Ida Unhammer Njerve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.